Cargando…
Systematic analysis of histone acetylation regulators across human cancers
BACKGROUND: Histone acetylation (HA) is an important and common epigenetic pathway, which could be hijacked by tumor cells during carcinogenesis and cancer progression. However, the important role of HA across human cancers remains elusive. METHODS: In this study, we performed a comprehensive analys...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408135/ https://www.ncbi.nlm.nih.gov/pubmed/37553641 http://dx.doi.org/10.1186/s12885-023-11220-7 |
_version_ | 1785086120122384384 |
---|---|
author | Song, Congkuan Liu, Xinfei Lin, Weichen Lai, Kai Pan, Shize Lu, Zilong Li, Donghang Li, Ning Geng, Qing |
author_facet | Song, Congkuan Liu, Xinfei Lin, Weichen Lai, Kai Pan, Shize Lu, Zilong Li, Donghang Li, Ning Geng, Qing |
author_sort | Song, Congkuan |
collection | PubMed |
description | BACKGROUND: Histone acetylation (HA) is an important and common epigenetic pathway, which could be hijacked by tumor cells during carcinogenesis and cancer progression. However, the important role of HA across human cancers remains elusive. METHODS: In this study, we performed a comprehensive analysis at multiple levels, aiming to systematically describe the molecular characteristics and clinical relevance of HA regulators in more than 10000 tumor samples representing 33 cancer types. RESULTS: We found a highly heterogeneous genetic alteration landscape of HA regulators across different human cancer types. CNV alteration may be one of the major mechanisms leading to the expression perturbations in HA regulators. Furthermore, expression perturbations of HA regulators correlated with the activity of multiple hallmark oncogenic pathways. HA regulators were found to be potentially useful for the prognostic stratification of kidney renal clear cell carcinoma (KIRC). Additionally, we identified HDAC3 as a potential oncogene in lung adenocarcinoma (LUAD). CONCLUSION: Overall, our results highlights the importance of HA regulators in cancer development, which may contribute to the development of clinical strategies for cancer treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11220-7. |
format | Online Article Text |
id | pubmed-10408135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104081352023-08-09 Systematic analysis of histone acetylation regulators across human cancers Song, Congkuan Liu, Xinfei Lin, Weichen Lai, Kai Pan, Shize Lu, Zilong Li, Donghang Li, Ning Geng, Qing BMC Cancer Research BACKGROUND: Histone acetylation (HA) is an important and common epigenetic pathway, which could be hijacked by tumor cells during carcinogenesis and cancer progression. However, the important role of HA across human cancers remains elusive. METHODS: In this study, we performed a comprehensive analysis at multiple levels, aiming to systematically describe the molecular characteristics and clinical relevance of HA regulators in more than 10000 tumor samples representing 33 cancer types. RESULTS: We found a highly heterogeneous genetic alteration landscape of HA regulators across different human cancer types. CNV alteration may be one of the major mechanisms leading to the expression perturbations in HA regulators. Furthermore, expression perturbations of HA regulators correlated with the activity of multiple hallmark oncogenic pathways. HA regulators were found to be potentially useful for the prognostic stratification of kidney renal clear cell carcinoma (KIRC). Additionally, we identified HDAC3 as a potential oncogene in lung adenocarcinoma (LUAD). CONCLUSION: Overall, our results highlights the importance of HA regulators in cancer development, which may contribute to the development of clinical strategies for cancer treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11220-7. BioMed Central 2023-08-08 /pmc/articles/PMC10408135/ /pubmed/37553641 http://dx.doi.org/10.1186/s12885-023-11220-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Song, Congkuan Liu, Xinfei Lin, Weichen Lai, Kai Pan, Shize Lu, Zilong Li, Donghang Li, Ning Geng, Qing Systematic analysis of histone acetylation regulators across human cancers |
title | Systematic analysis of histone acetylation regulators across human cancers |
title_full | Systematic analysis of histone acetylation regulators across human cancers |
title_fullStr | Systematic analysis of histone acetylation regulators across human cancers |
title_full_unstemmed | Systematic analysis of histone acetylation regulators across human cancers |
title_short | Systematic analysis of histone acetylation regulators across human cancers |
title_sort | systematic analysis of histone acetylation regulators across human cancers |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408135/ https://www.ncbi.nlm.nih.gov/pubmed/37553641 http://dx.doi.org/10.1186/s12885-023-11220-7 |
work_keys_str_mv | AT songcongkuan systematicanalysisofhistoneacetylationregulatorsacrosshumancancers AT liuxinfei systematicanalysisofhistoneacetylationregulatorsacrosshumancancers AT linweichen systematicanalysisofhistoneacetylationregulatorsacrosshumancancers AT laikai systematicanalysisofhistoneacetylationregulatorsacrosshumancancers AT panshize systematicanalysisofhistoneacetylationregulatorsacrosshumancancers AT luzilong systematicanalysisofhistoneacetylationregulatorsacrosshumancancers AT lidonghang systematicanalysisofhistoneacetylationregulatorsacrosshumancancers AT lining systematicanalysisofhistoneacetylationregulatorsacrosshumancancers AT gengqing systematicanalysisofhistoneacetylationregulatorsacrosshumancancers |